Davis's Drug Guide
Namzaric 28/10
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Namzaric 28/10." Davis's Drug Guide, 19th ed., F.A. Davis Company, 2024. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110629/all/Namzaric_28_10.
Vallerand AHA, Sanoski CAC, Quiring CC. Namzaric 28/10. Davis's Drug Guide. F.A. Davis Company; 2024. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110629/all/Namzaric_28_10. Accessed November 14, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2024). Namzaric 28/10. In Davis's Drug Guide (19th ed.). F.A. Davis Company. https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110629/all/Namzaric_28_10
Vallerand AHA, Sanoski CAC, Quiring CC. Namzaric 28/10 [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2024. [cited 2024 November 14]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110629/all/Namzaric_28_10.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Namzaric 28/10
ID - 110629
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Davis-Drug-Guide/110629/all/Namzaric_28_10
PB - F.A. Davis Company
ET - 19
DB - Pediatrics Central
DP - Unbound Medicine
ER -
